The global drug discovery services market size is expected to reach around US$ 33.2 billion by 2030 from US$ 12.68 billion in 2021 and is expected to grow at an impressive double-digit rate of 11.3% from 2021 to 2030.
The rising elderly population, rising prevalence of ear nose throat (ENT)-related illnesses, and rising adoption of less invasive ear nose throat (ENT) operations are some of the significant market drivers of the ear nose throat (ENT) treatment market.
The study includes drivers and restraints of this market. The study provides an analysis of the global drug discovery services market for the period 2017-2030, wherein 2021 to 2030 is the forecast period and 2020 is considered as the base year.
Download Free Sample Copy Here (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/sample/1534
Why should you invest in this report?
If you are aiming to enter the global drug discovery services market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for drug discovery services are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030, so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Some of the prominent players in the global drug discovery services market include:
- Novartis AG
- Pfizer Inc.
- GlaxoSmithKline Pharmaceuticals
- Teva Pharmaceuticals Industries Ltd.
- Sonova Holding AG
- Starkey Laboratories Inc.
- Siemens Healthcare
- Sonic Innovations Inc.
- American Hearing Systems Inc.
- Dr. Reddy’s Laboratories Ltd.
Market Segmentation:
By Devices
- Hearing Aid Devices
- Voice Prosthesis
- Nasal Splints
- Hearing Implants
- Endoscopes
- Others
By Drug Type
- Antibiotics
- Antihistamines
- Steroids
- Anti-inflammatory Drugs
- Others
By Organ Type
- Ear
- Nose
- Throat
By End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Home Care Settings
- Others
Regional Analysis:
The geographical analysis of the global drug discovery services market has been done for North America, Europe, Asia-Pacific, and the Rest of the World.
The North American Market is again segmented into the US, Canada, and Mexico. Coming to the European Market, it can be segmented further into the UK, Germany, France, Italy, Spain, and the rest. Coming to the Asia-Pacific, the global drug discovery services Market is segmented into China, India, Japan, and Rest of Asia Pacific. Among others, the market is segmented into the Middle East and Africa, (GCC, North Africa, South Africa and Rest of the Middle East & Africa).
Key Questions Answered by the Report:
- What will be the size of the global drug discovery services market in 2030?
- What is the expected CAGR for the drug discovery services market between 2021 and 2030?
- Which are the top players active in this global market?
- What are the key drivers of this global market?
- How will the market situation change in the coming years?
- Which region held the highest market share in this global market?
- What are the common business tactics adopted by players?
- What is the growth outlook of the global drug discovery services market?
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Ear Nose Throat (ENT) Treatment Market
5.1. COVID-19 Landscape: Ear Nose Throat (ENT) Treatment Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Ear Nose Throat (ENT) Treatment Market, By Devices
8.1. Ear Nose Throat (ENT) Treatment Market, by Devices Type, 2021-2030
8.1.1. Hearing Aid Devices
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Voice Prosthesis
8.1.2.1. Market Revenue and Forecast (2019-2030)
8.1.3. Nasal Splints
8.1.3.1. Market Revenue and Forecast (2019-2030)
8.1.4. Hearing Implants
8.1.4.1. Market Revenue and Forecast (2019-2030)
8.1.5. Endoscopes
8.1.5.1. Market Revenue and Forecast (2019-2030)
8.1.6. Others
8.1.6.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Ear Nose Throat (ENT) Treatment Market, By Drug Type
9.1. Ear Nose Throat (ENT) Treatment Market, by Drug Type, 2021-2030
9.1.1. Antibiotics
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Antihistamines
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. Steroids
9.1.3.1. Market Revenue and Forecast (2019-2030)
9.1.4. Anti-inflammatory Drugs
9.1.4.1. Market Revenue and Forecast (2019-2030)
9.1.5. Others
9.1.5.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Ear Nose Throat (ENT) Treatment Market, By Organ Type
10.1. Ear Nose Throat (ENT) Treatment Market, by Organ Type, 2021-2030
10.1.1. Ear
10.1.1.1. Market Revenue and Forecast (2019-2030)
10.1.2. Nose
10.1.2.1. Market Revenue and Forecast (2019-2030)
10.1.3. Throat
10.1.3.1. Market Revenue and Forecast (2019-2030)
Chapter 11. Global Ear Nose Throat (ENT) Treatment Market, By End User
11.1. Ear Nose Throat (ENT) Treatment Market, by End User, 2021-2030
11.1.1. Hospitals
11.1.1.1. Market Revenue and Forecast (2019-2030)
11.1.2. Clinics
11.1.2.1. Market Revenue and Forecast (2019-2030)
11.1.3. Ambulatory Surgical Centers
11.1.3.1. Market Revenue and Forecast (2019-2030)
11.1.4. Home Care Settings
11.1.4.1. Market Revenue and Forecast (2019-2030)
11.1.5. Others
11.1.5.1. Market Revenue and Forecast (2019-2030)
Chapter 12. Global Ear Nose Throat (ENT) Treatment Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Devices (2019-2030)
12.1.2. Market Revenue and Forecast, by Drug Type (2019-2030)
12.1.3. Market Revenue and Forecast, by Organ Type (2019-2030)
12.1.4. Market Revenue and Forecast, by End User (2019-2030)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Devices (2019-2030)
12.1.5.2. Market Revenue and Forecast, by Drug Type (2019-2030)
12.1.5.3. Market Revenue and Forecast, by Organ Type (2019-2030)
12.1.5.4. Market Revenue and Forecast, by End User (2019-2030)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Devices (2019-2030)
12.1.6.2. Market Revenue and Forecast, by Drug Type (2019-2030)
12.1.6.3. Market Revenue and Forecast, by Organ Type (2019-2030)
12.1.6.4. Market Revenue and Forecast, by End User (2019-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Devices (2019-2030)
12.2.2. Market Revenue and Forecast, by Drug Type (2019-2030)
12.2.3. Market Revenue and Forecast, by Organ Type (2019-2030)
12.2.4. Market Revenue and Forecast, by End User (2019-2030)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Devices (2019-2030)
12.2.5.2. Market Revenue and Forecast, by Drug Type (2019-2030)
12.2.5.3. Market Revenue and Forecast, by Organ Type (2019-2030)
12.2.5.4. Market Revenue and Forecast, by End User (2019-2030)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Devices (2019-2030)
12.2.6.2. Market Revenue and Forecast, by Drug Type (2019-2030)
12.2.6.3. Market Revenue and Forecast, by Organ Type (2019-2030)
12.2.6.4. Market Revenue and Forecast, by End User (2019-2030)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Devices (2019-2030)
12.2.7.2. Market Revenue and Forecast, by Drug Type (2019-2030)
12.2.7.3. Market Revenue and Forecast, by Organ Type (2019-2030)
12.2.7.4. Market Revenue and Forecast, by End User (2019-2030)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Devices (2019-2030)
12.2.8.2. Market Revenue and Forecast, by Drug Type (2019-2030)
12.2.8.3. Market Revenue and Forecast, by Organ Type (2019-2030)
12.2.8.4. Market Revenue and Forecast, by End User (2019-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Devices (2019-2030)
12.3.2. Market Revenue and Forecast, by Drug Type (2019-2030)
12.3.3. Market Revenue and Forecast, by Organ Type (2019-2030)
12.3.4. Market Revenue and Forecast, by End User (2019-2030)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Devices (2019-2030)
12.3.5.2. Market Revenue and Forecast, by Drug Type (2019-2030)
12.3.5.3. Market Revenue and Forecast, by Organ Type (2019-2030)
12.3.5.4. Market Revenue and Forecast, by End User (2019-2030)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Devices (2019-2030)
12.3.6.2. Market Revenue and Forecast, by Drug Type (2019-2030)
12.3.6.3. Market Revenue and Forecast, by Organ Type (2019-2030)
12.3.6.4. Market Revenue and Forecast, by End User (2019-2030)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Devices (2019-2030)
12.3.7.2. Market Revenue and Forecast, by Drug Type (2019-2030)
12.3.7.3. Market Revenue and Forecast, by Organ Type (2019-2030)
12.3.7.4. Market Revenue and Forecast, by End User (2019-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Devices (2019-2030)
12.3.8.2. Market Revenue and Forecast, by Drug Type (2019-2030)
12.3.8.3. Market Revenue and Forecast, by Organ Type (2019-2030)
12.3.8.4. Market Revenue and Forecast, by End User (2019-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Devices (2019-2030)
12.4.2. Market Revenue and Forecast, by Drug Type (2019-2030)
12.4.3. Market Revenue and Forecast, by Organ Type (2019-2030)
12.4.4. Market Revenue and Forecast, by End User (2019-2030)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Devices (2019-2030)
12.4.5.2. Market Revenue and Forecast, by Drug Type (2019-2030)
12.4.5.3. Market Revenue and Forecast, by Organ Type (2019-2030)
12.4.5.4. Market Revenue and Forecast, by End User (2019-2030)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Devices (2019-2030)
12.4.6.2. Market Revenue and Forecast, by Drug Type (2019-2030)
12.4.6.3. Market Revenue and Forecast, by Organ Type (2019-2030)
12.4.6.4. Market Revenue and Forecast, by End User (2019-2030)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Devices (2019-2030)
12.4.7.2. Market Revenue and Forecast, by Drug Type (2019-2030)
12.4.7.3. Market Revenue and Forecast, by Organ Type (2019-2030)
12.4.7.4. Market Revenue and Forecast, by End User (2019-2030)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Devices (2019-2030)
12.4.8.2. Market Revenue and Forecast, by Drug Type (2019-2030)
12.4.8.3. Market Revenue and Forecast, by Organ Type (2019-2030)
12.4.8.4. Market Revenue and Forecast, by End User (2019-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Devices (2019-2030)
12.5.2. Market Revenue and Forecast, by Drug Type (2019-2030)
12.5.3. Market Revenue and Forecast, by Organ Type (2019-2030)
12.5.4. Market Revenue and Forecast, by End User (2019-2030)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Devices (2019-2030)
12.5.5.2. Market Revenue and Forecast, by Drug Type (2019-2030)
12.5.5.3. Market Revenue and Forecast, by Organ Type (2019-2030)
12.5.5.4. Market Revenue and Forecast, by End User (2019-2030)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Devices (2019-2030)
12.5.6.2. Market Revenue and Forecast, by Drug Type (2019-2030)
12.5.6.3. Market Revenue and Forecast, by Organ Type (2019-2030)
12.5.6.4. Market Revenue and Forecast, by End User (2019-2030)
Chapter 13. Company Profiles
13.1. Novartis AG
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Pfizer Inc.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. GlaxoSmithKline Pharmaceuticals
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Teva Pharmaceuticals Industries Ltd.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Sonova Holding AG
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Starkey Laboratories Inc.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Siemens Healthcare
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Sonic Innovations Inc.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. American Hearing Systems Inc.
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Dr. Reddy’s Laboratories Ltd.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Buy Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1534
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
0 Comments